ROS mediated Cu [Fe (CN) 5NO] nanoparticles for triple negative breast cancer: A detailed study in preclinical mouse model

S Tripathy, S Haque, S Londhe, S Das, CC Norbert… - Biomaterials …, 2024 - Elsevier
Triple negative breast cancer (TNBC) is an aggressive form of tumor, more prevalent in
younger women resulting in poor survival rate (2nd in cancer deaths) because of its …

Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer …

M Ahir, S Bhattacharya, S Karmakar, A Mukhopadhyay… - Biomaterials, 2016 - Elsevier
Metal oxide nanoparticles are the forthcoming anti-tumor therapeutics and provide a
versatile platform in the development of therapeutic approaches for drug-resistant cancers …

Copper nitroprusside analogue nanoparticles against melanoma: Detailed in vitro and in vivo investigation

S Tripathy, S Londhe, A Patel, S Saha, Y Chandra… - Nanoscale, 2024 - pubs.rsc.org
Melanoma is the most invasive and lethal form of skin cancer that arises from the malignant
transformation of specialized pigmented cell melanocytes. Nanomedicine represents an …

Biofabrication of ecofriendly copper oxide nanoparticles and their applications in breast cancer therapy

AP Roy, S Mitra, S Sarkar, R Sahu, G Nandi… - Inorganic Chemistry …, 2023 - Elsevier
Metal oxide nanoparticles are gaining close attention in recent years due to their varied
physicochemical characteristics and applications in various fields, particularly nanomedicine …

Development of triphala churna extract mediated iron oxide nanoparticles as novel treatment strategy for triple negative breast cancer

A Parmanik, A Bose, B Ghosh, M Paul, A Itoo… - Journal of Drug Delivery …, 2022 - Elsevier
The present work demonstrates the eco-friendly green synthesis of Iron oxide nanoparticles
from the aqueous extract of Triphala churna (TIONPs) using ferric chloride hexahydrate …

DUCNP@ Mn–MOF/FOE as a highly selective and bioavailable drug delivery system for synergistic combination cancer therapy

X Zhao, S He, B Li, B Liu, Y Shi, W Cong, F Gao… - Nano Letters, 2023 - ACS Publications
Heterostructures comprising lanthanide-doped upconversion nanoparticles (DUCNPs) and
metal–organic frameworks (MOFs) are emerging as promising nanosystems for integrating …

Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance

J Yang, Z Jia, J Zhang, X Pan, Y Wei… - Advanced …, 2022 - Wiley Online Library
Triple‐negative breast cancer (TNBC) patients have a predisposition to poor prognosis due
to the strong malignancy. Ferroptosis, a new form of cell death, is a candidate treatment for …

Copper nanoparticles green synthesis and characterization as anticancer potential in breast cancer cells (MCF7) derived from Prunus nepalensis phytochemicals

SS Biresaw, P Taneja - Materials Today: Proceedings, 2022 - Elsevier
The green synthesis of nanoparticles from bioactive compounds have attracted a wide range
of application, due to increased drug efficacy and less toxicity in the nanosized mediated …

Transactivator of transcription peptide conjugated copper oxide nanoparticles: A nano-warrior against breast cancer-Insights from biosynthesis, characterization, and …

R Muthukumarasamy, S Majeed, M Danish… - Journal of Drug Delivery …, 2023 - Elsevier
Nanobiotechnology presents novel opportunities for the treatment of diverse forms of cancer
at the nanoscale, exhibiting an outstanding level of effectiveness. Copper oxide …

Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer

H Wen, P Poutiainen, E Batnasan, L Latonen, VP Lehto… - Pharmaceutics, 2023 - mdpi.com
Mesoporous silicon nanoparticles (PSi NPs) are promising platforms of nanomedicine
because of their good compatibility, high payload capacities of anticancer drugs, and easy …